Andrea Martani, Nathalie Neeser, Nicolas Vulliemoz, Guido Pennings
{"title":"Challenges for the legislation enabling egg donation in Switzerland.","authors":"Andrea Martani, Nathalie Neeser, Nicolas Vulliemoz, Guido Pennings","doi":"10.1177/09685332241269583","DOIUrl":null,"url":null,"abstract":"<p><p>Switzerland is one of the most restrictive countries in Europe when it comes to the regulation of egg donation in medically assisted reproduction (MAR). Indeed, even after the introduction of modifications to the law regulating reproductive medicine allowing embryo culture, embryo freezing, and preimplantation genetic testing, egg donation has remained completely forbidden. The absolute ban on egg donation is heavily discussed in academia, society, and politics. After many failed attempts, this prohibition is now on its way to be lifted, after agreement was reached in the legislative institutions. The forthcoming legalisation of egg donation raises, however, several questions on how some aspects of this practice will be regulated. In this contribution, we briefly review the reasons why a ban on egg donation has been present for so long in Switzerland, to then analyse two issues raised by the commitment to lift this ban. First, we reflect on the question of whether the new legislation should introduce chronological age limits for access to heterologous MAR. Second, we consider how the practice of egg sharing could be regulated once egg donation is legal.</p>","PeriodicalId":39602,"journal":{"name":"Medical Law International","volume":"24 3","pages":"192-216"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502263/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Law International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/09685332241269583","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0
Abstract
Switzerland is one of the most restrictive countries in Europe when it comes to the regulation of egg donation in medically assisted reproduction (MAR). Indeed, even after the introduction of modifications to the law regulating reproductive medicine allowing embryo culture, embryo freezing, and preimplantation genetic testing, egg donation has remained completely forbidden. The absolute ban on egg donation is heavily discussed in academia, society, and politics. After many failed attempts, this prohibition is now on its way to be lifted, after agreement was reached in the legislative institutions. The forthcoming legalisation of egg donation raises, however, several questions on how some aspects of this practice will be regulated. In this contribution, we briefly review the reasons why a ban on egg donation has been present for so long in Switzerland, to then analyse two issues raised by the commitment to lift this ban. First, we reflect on the question of whether the new legislation should introduce chronological age limits for access to heterologous MAR. Second, we consider how the practice of egg sharing could be regulated once egg donation is legal.
瑞士是欧洲对医学辅助生殖(MAR)中卵子捐赠管理最严格的国家之一。事实上,即使在对生殖医学法律进行修改,允许胚胎培养、胚胎冷冻和胚胎植入前基因检测后,卵子捐赠仍被完全禁止。学术界、社会和政界对绝对禁止捐卵进行了大量讨论。经过多次尝试失败后,在立法机构达成一致意见后,这一禁令即将被取消。然而,即将到来的捐卵合法化引发了一些问题,即如何对这一做法的某些方面进行监管。在本文中,我们将简要回顾瑞士长期以来禁止捐献卵子的原因,然后分析承诺取消这一禁令所引发的两个问题。首先,我们思考了新立法是否应引入获取异源 MAR 的年龄限制问题。其次,我们考虑一旦卵子捐赠合法化,如何规范共享卵子的做法。
期刊介绍:
The scope includes: Clinical Negligence. Health Matters Affecting Civil Liberties. Forensic Medicine. Determination of Death. Organ and Tissue Transplantation. End of Life Decisions. Legal and Ethical Issues in Medical Treatment. Confidentiality. Access to Medical Records. Medical Complaints Procedures. Professional Discipline. Employment Law and Legal Issues within NHS. Resource Allocation in Health Care. Mental Health Law. Misuse of Drugs. Legal and Ethical Issues concerning Human Reproduction. Therapeutic Products. Medical Research. Cloning. Gene Therapy. Genetic Testing and Screening. And Related Topics.